Galapagos
![Jyseleca Withdrawn in Europe: Galapagos Cuts Sales Forecast](https://pharmtales.com/wp-content/uploads/2023/08/Galapagos-Drops-Jyseleca-in-Europe-Lowers-Sales-Outlook.jpg)
Galapagos Drops Jyseleca in Europe, Lowers Sales Outlook
SG Tylor
Galapagos has suffered a significant setback as it decided not to submit a Marketing Authorization Application (MAA) for its drug ...
Galapagos has suffered a significant setback as it decided not to submit a Marketing Authorization Application (MAA) for its drug ...